availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial
Regular use can lead to lowered cholesterol levels, supporting overall cardiovascular health
At-Home Blood Test CLIA lab processing
This formulation delivers a synergistic blend that targets lipid metabolism , hepatic function , and cellular energy production , making it highly effective for patients undergoing fat-loss regimens , recovering from nutritional deficiencies , or requiring enhanced methylation support
Street parking is available on Burlington Avenue, with a public lot nearby
Most patients start to experience these treatment benefits during the initial weeks of their therapy
